Down Syndrome Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Down Syndrome Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Down Syndrome Market by Disease: Market Size and Forecast, 2019 - 2028

4.1  Overview

4.2  Trisomy 21

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Million)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

4.3  Translocation Down Syndrome

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Million)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

4.4  Mosaic Down Syndrome

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Million)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

Chapter 5        Global Down Syndrome Market by Test: Market Size and Forecast, 2019 – 2028 

5.1  Overview

5.2  Screening Tests

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Million)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

5.3  Triple Screen

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Million)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

5.4  Quad Screen

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Million)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

5.5  Diagnostic Tests

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Million)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

Chapter 6    Global Down Syndrome Market by Distribution Channel: Market Size and Forecast, 2019 – 2028

6.1  Hospital Pharmacy

6.1.1   Current Trend and Analysis

6.1.2   Market Size and Forecast, 2019 - 2028 ($ Million)

6.1.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

6.2  Retail Pharmacy

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Million)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

6.3  Online Pharmacy

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Million)

6.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

Chapter 7    Global Down Syndrome Market by End User: Market Size and Forecast, 2019 – 2028

7.1  Hospitals

7.1.1   Current Trend and Analysis

7.1.2   Market Size and Forecast, 2019 - 2028 ($ Million)

7.1.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

7.2  Homecare

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Million)

7.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million)

7.3  Specialty Clinics

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Million)

7.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Million

Chapter 8        Global Down Syndrome Market by Geography: Market Size and Forecast, 2019 - 2028 

8.1  Overview

8.1.1   Global Down Syndrome Market Year-on-Year Growth, by region 2020 – 2028 (%)

8.2  North America

8.2.1   Current Trend and Analysis

8.2.2   Market Size and Forecast, 2019 - 2028 ($ Million)

8.2.3   U.S.

8.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.2.3.2        By Disease

8.2.3.3        By Test

8.2.3.4        By Distribution Channel

8.2.3.5        By End Use

8.2.4   Canada

8.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.2.4.2        By Disease

8.2.4.3        By Test

8.2.4.4        By Distribution Channel

8.2.4.5        By End Use

8.2.5   Mexico

8.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.2.5.2        By Disease

8.2.5.3        By Test

8.2.5.4        By Distribution Channel

8.2.5.5        By End Use

8.3    Europe

8.3.1   Current Trend and Analysis

8.3.2   Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.3   UK

8.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.3.2        By Disease

8.3.3.3        By Test

8.3.3.4        By Distribution Channel

8.3.3.5        By End Use

8.3.4   Russia

8.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.4.2        By Disease

8.3.4.3        By Test

8.3.4.4        By Distribution Channel

8.3.4.5        By End Use

8.3.5   France

8.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.5.2        By Disease

8.3.5.3        By Test

8.3.5.4        By Distribution Channel

8.3.5.5        By End Use

8.3.6   Italy

8.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.6.2        By Disease

8.3.6.3        By Test

8.3.6.4        By Distribution Channel

8.3.6.5        By End Use

8.3.7   Germany

8.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.7.2        By Disease

8.3.7.3        By Test

8.3.7.4        By Distribution Channel

8.3.7.5        By End Use

8.3.8   Rest of Europe

8.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.3.8.2        By Disease

8.3.8.3        By Test

8.3.8.4        By Distribution Channel

8.3.8.5        By End Use

8.4    Asia-Pacific

8.4.1   Current Trend and Analysis

8.4.2   Market Size and Forecast, 2019 - 2028 ($ Million)

8.4.3   China

8.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.4.3.2        By Disease

8.4.3.3        By Test

8.4.3.4        By Distribution Channel

8.4.3.5        By End Use

8.4.4   India

8.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.4.4.2        By Disease

8.4.4.3        By Test

8.4.4.4        By Distribution Channel

8.4.4.5        By End Use

8.4.5   Japan

8.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.4.5.2        By Disease

8.4.5.3        By Test

8.4.5.4        By Distribution Channel

8.4.5.5        By End Use

8.4.6   Rest of Asia-Pacific

8.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.4.6.2        By Disease

8.4.6.3        By Test

8.4.6.4        By Distribution Channel

8.4.6.5        By End Use

8.5    RoW

8.5.1   Current Trend and Analysis

8.5.2   Market Size and Forecast

8.5.3   South America

8.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.5.3.2        By Disease

8.5.3.3        By Test

8.5.3.4        By Distribution Channel

8.5.3.5        By End Use

8.5.4   Middle East

8.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.5.4.2        By Disease

8.5.4.3        By Test

8.5.4.4        By Distribution Channel

8.5.4.5        By End Use

8.5.5   Africa

8.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Million)

8.5.5.2        By Disease

8.5.5.3        By Test

8.5.5.4        By Distribution Channel

8.5.5.5        By End Use

Chapter 9        Company Profiles

9.1  Illumina, Inc.

9.1.1     Company Overview

9.1.2     Product Portfolio

9.1.3     Business Strategies

9.1.4     Financials

9.1.5     Recent Developments

9.2  AC Immune SAS

9.2.1     Company Overview

9.2.2     Product Portfolio

9.2.3     Business Strategies

9.2.4     Financials

9.2.5     Recent Developments

9.3  Pfizer Inc.

9.3.1     Company Overview

9.3.2     Product Portfolio

9.3.3     Business Strategies

9.3.4     Financials

9.3.5     Recent Developments

9.4  Bayer AG.

9.4.1     Company Overview

9.4.2     Product Portfolio

9.4.3     Business Strategies

9.4.4     Financials

9.4.5     Recent Developments

9.5  Annovis Bio Inc.

9.5.1     Company Overview

9.5.2     Product Portfolio

9.5.3     Business Strategies

9.5.4     Financials

9.5.5     Recent Developments

9.6  Avanti Biosciences Inc.

9.6.1     Company Overview

9.6.2     Product Portfolio

9.6.3     Business Strategies

9.6.4     Financials

9.6.5     Recent Developments

9.7  Balance Therapeutics Inc.

9.7.1     Company Overview

9.7.2     Product Portfolio

9.7.3     Business Strategies

9.7.4     Financials

9.7.5     Recent Developments

9.8  Eisai Co Ltd.

9.8.1     Company Overview

9.8.2     Product Portfolio

9.8.3     Business Strategies

9.8.4     Financials

9.8.5     Recent Developments

9.9  Elixirgen Therapeutics LLC.

9.9.1     Company Overview

9.9.2     Product Portfolio

9.9.3     Business Strategies

9.9.4     Financials

9.9.5     Recent Developments

9.10   Back to top

Payment Options

Single User $5295
Five User $6195
Enterprise $8199
Datapack $2199
Short Report: $3099